A single-centre evaluation of two new anti-Müllerian hormone assays and comparison with the current clinical standard assay

Human Reproduction

Volumn 29, Issue 5, 2014, Pages 1035-1041

  Welsh, Paul ^a,c   Smith, Karen ^b   Nelson, Scott M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

AMH; anti Mullerian hormone; immunoassay; ovarian reserve; validation studies

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ANTIMULLERIAN HORMONE ASSAY; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INTERMETHOD COMPARISON; LIMIT OF DETECTION; OVARIAN RESERVE; QUALITY CONTROL; COMPARATIVE STUDY; EVALUATION STUDY; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ANTI-MULLERIAN HORMONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 84898919499     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu036     Document Type: Article

References (18)

1. Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008;29(Suppl. 1):S49-s52.
2. Bentzen JG, Forman JL, Larsen EC, Pinborg A, Johannsen TH, Schmidt L, Friis-Hansen L, Nyboe Andersen A. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age. Hum Reprod 2013;28:247-255.
3. Carletta J. Assessing agreement on classification tasks: the kappa statistic. Comput Linguist 1992;22:249-254.
4. Clark CA, Laskin CA, Cadesky K. Anti-Mullerian hormone: reality check. Hum Reprod 2014;29:184-185.
5. Hagen CP, Aksglaede L, Sorensen K, Mouritsen A, Andersson AM, Petersen JH, Main KM, Juul A. Individual serum levels of anti-Mullerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Hum Reprod 2012;27:861-866.
6. Henry NL, Xia R, Schott AF, Mc Connell D, Banerjee M, Hayes DF. Prediction of post-chemotherapy ovarian function using markers of ovarian reserve. Oncologist 2014;19:68-74.
7. Homburg R, Ray A, Bhide P, Gudi A, Shah A, Timms P, Grayson K. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study. Hum Reprod 2013;28:1077-1083.
8. Kumar A, Kalra B, Patel A, Mc David L, Roudebush WE. Development of a second generation anti-Mullerian hormone (AMH) ELISA. J Immunol Methods 2010;362:51-59.
9. Kumar A, Kalra B, Patel AS, Shah S. Development of a well characterized ultra-sensitive human anti-Müllerian hormone (AMH) ELISA AACC 2013 A-349. http://www.aacc.org/events/Annual-Meeting/abstracts/Documents/ AACC-13-AM-A279-A363.pdf.
10. MHRA (Medicines and Healthcare products Regulatory Agency). Urgent Field Safety Notice-FSN 20434-3 AMH Gen II ELISA (REF A79765), 2013. http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con297532. pdf.
11. Nelson SM. Biomarkers of ovarian response: current and future applications. Ovarian Reserve Oocytes 2013;99:963-969.
12. Nelson SM, Messow MC, Wallace AM, Fleming R, Mc Connachie A. Nomogram for the decline in serum antiMullerian hormone: a population study of 9, 601 infertility patients. Fertil Steril 2011;95:736-741.
13. Nelson SM, Iliodromiti S, Fleming R, Anderson R, Mc Connachie A, Messow CM. Reference range for the antiMüllerian hormone Generation II assay: a population study of 10, 984 women, with comparison to the established Diagnostics Systems Laboratory nomogram. Fertil Steril 2014; 101:523-529.
14. NICE (National Institute for Health and Clinical Excellence). Fertility: Assessment and treatment for people with fertility problems. NICE Clinical Guideline 156, 2013. http://www.nice.org.uk/nicemedia/live/14078/62769/62769. pdf.
15. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 1983; 21:709-720.
16. Rustamov O, Smith A, Roberts SA, Yates AP, Fitzgerald C, Krishnan M, Nardo LG, Pemberton PW. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Hum Reprod 2012;27:3085-3091.
17. Wallace AM, Faye SA, Fleming R, Nelson SM. A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II). Ann Clin Biochem 2011;48:370-373.
18. Yates AP, Rustamov O, Roberts SA, Lim HY, Pemberton PW, Smith A, Nardo LG. Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst mreducing adverse effects and costs of IVF. Hum Reprod. 2011;26:2353-2362.